This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Intersections Inc. Reports Second Quarter 2014 Results

Intersections Inc. (NASDAQ: INTX) today announced financial results for the quarter ended June 30, 2014. Consolidated revenue for the quarter ended June 30, 2014 was $64.3 million, as compared to $80.7 million for the quarter ended June 30, 2013. Consolidated adjusted EBITDA before share related compensation and non-cash impairment charges for the quarter ended June 30, 2014 was $1.2 million, compared to $9.5 million for the quarter ended June 30, 2013. Net (loss) for the quarter ended June 30, 2014 was $(2.0) million, as compared to net income of $1.6 million for the quarter ended June 30, 2013. Consolidated revenue for the six months ended June 30, 2014 was $130.3 million, as compared to $162.3 million for the six months ended June 30, 2013. Consolidated adjusted EBITDA before share related compensation and non-cash impairment charges for the six months ended June 30, 2014 was $3.3 million compared to $19.9 million for the six months ended June 30, 2013. Net (loss) for the six months ended June 30, 2014 was $(4.8) million, compared to net income of $3.8 million for the six months ended June 30, 2013. Diluted loss per share was $(0.26) for the six months ended June 30, 2014, as compared to diluted earnings per share of $0.20 for the six months ended June 30, 2013. As of June 30, 2014, we had a cash and cash equivalents balance of $12.4 million.

Michael Stanfield, Chairman and Chief Executive Officer of Intersections commented, “We are encouraged by our second quarter results and look forward to the next several months as we continue to reignite growth at Intersections by focusing on our Identity Guard® brand and the upcoming launch of VOYCE TM, our new pet health technology platform. We are in the process of formulating a detailed plan intended to streamline operations with a focus on our corporate and consumer products and services cost structure, which we intend to present later this month to our Board of Directors for approval. If this plan is approved or we otherwise undertake additional cost-cutting initiatives, we would expect our severance expense and cash used in operations to increase for the remainder of 2014, followed thereafter by reductions to our cost of revenue and general and administrative expenses. We anticipate providing more information about our plan, as well as updated guidance in the coming weeks.”

Second Quarter 2014 Financial Highlights:

  • Total subscribers as of June 30, 2014 decreased to approximately 2.3 million compared to 3.8 million as of June 30, 2013, approximately 46 thousand of whom remain in a non-billable status.
  • Consolidated net loss per share for the quarter ended June 30, 2014 was $(0.11) per diluted share, compared to consolidated net income per share of $0.08 per diluted share, for the quarter ended June 30, 2013.
  • Our Pet Health Monitoring segment generated a loss from operations in the quarter ended June 30, 2014 of approximately $(3.2) million which was funded from available cash on hand. This segment has not yet commenced sales and is expected to launch later in 2014.
  • Consolidated cash flow used in operations for the quarter ended June 30, 2014 was approximately $4.1 million.
  • We amended our Credit Agreement during the quarter to provide for a $7.5 million revolving credit facility with a maturity date of March 31, 2015. The amendment also modified our financial covenants and restricts our ability to pay ordinary dividends and make share repurchases. As of June 30, 2014, we are able to borrow the full amount available under the Credit Agreement.

Six Months Results:

  • Our Pet Health Monitoring segment generated a loss from operations of approximately $(6.5) million which was funded from available cash on hand.
  • Consolidated cash flow provided by operations for the six months ended June 30, 2014 was approximately $1.5 million.

In the three months ended June 30, 2014, we ceased all business activities in our subsidiary Intersections Business Intelligence Services (D/B/A) Zumetrics®, which was included in our Market Intelligence Segment. We determined that Zumetrics® met the requirements for classification as a discontinued operation under U.S. GAAP and we have recast our condensed consolidated statements of operations for the periods presented. Loss from discontinued operations, net of tax, was $318 thousand and $1.1 million for the three and six months ended June 30, 2014, respectively.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,120.78 +40.64 0.22%
S&P 500 2,121.90 +4.21 0.20%
NASDAQ 5,102.2320 +10.1470 0.20%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs